Global Melanoma Therapeutics market to grow at a CAGR of 15.40% over the period 2014-2019; Finds New Report

Report forecast the Global Melanoma Therapeutics market to grow at a CAGR of 15.40 percent over the period 2014-2019.

According to Melanoma Research Foundation, melanoma is usually, but not always, a cancer of the skin. Melanoma is defined as a cancer that occurs in melanocytes (cells that make the pigment melanin). Chest and back in men and legs in women are the most likely parts to be affected with melanoma. CM, MM, and OM are the three major categories of melanoma. The exact etiology of melanoma is unknown. According to the American Skin Association, the incidence of melanoma is increasing worldwide. The median age of diagnosis is 59 years and the median age of death due to melanoma is 67 years.

This report covers the present scenario and the growth prospects of the Global Melanoma Therapeutics market for the period 2015-2019. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment of melanoma that are available in the market. The market is divided into four segments: CM, OM, MM, and Others.

According to the report, the number of people being diagnosed with melanoma has increased worldwide. The high prevalence of melanoma among people has increased the demand for drugs used in the treatment of the disease.

Further, the report states that the availability of alternative treatment options such as chemotherapy, radiation therapy, and surgery limits the consumption of melanoma drugs by the patient population. In radiation therapy, ionizing rays are used to destroy the cancerous cells. Surgery, on the other hand, involves the removal of the tumor and is effective only at the early stages of melanoma.

Global Melanoma Therapeutics Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key players in the Global Melanoma Therapeutics Market: Bristol-Myers Squibb Co., F. Hoffmann-La Roche Ltd. and Merck & Co. Inc.

Other Prominent Vendors in the market are: AB Science, Amgen, Bayer, Celgene, Daiichi Sankyo, Eisai, GSK, Novartis, Pfizer, Vical and ZIOPHARM

Key Regions

• Americas
• APAC
• EMEA

Market Driver

• Increase in Prevalence of Melanoma
• For a full, detailed list, view our report

Market Challenge

• Availability of Alternative Treatments
• For a full, detailed list, view our report

Market Trend

• Emergence of Combination Therapies
• For a full, detailed list, view our report

Key Questions Answered in this Report

• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Spanning over 67 pages, “Global Melanoma Therapeutics Market 2015-2019” report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Disease Overview, Market Landscape, Melanoma Pipeline Landscape,  Market Segmentation by Category, Geographical Segmentation, Buying Criteria, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Key Vendor Analysis.

For further information on this report, please visit- http://mrr.cm/4YC

Find all Therapeutic Reports at: http://www.marketresearchreports.com/therapeutic